Skip to content

Clinical Characteristics and Molecular Mechanisms of Intracranial Teratoma Growth Syndrome in Children

Clinical Characteristics and Molecular Mechanisms of Intracranial Teratoma Growth Syndrome in Children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124309
Enrollment
Unknown
Registered
2026-05-10
Start date
2026-05-11
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Teratoma Growth Syndrome in children is characterized by germ cell tumor patients showing normal or decreasing tumor marker levels during or after radiochemotherapy, while experiencing rapid tumor volume growth predominantly composed of mature teratoma components.

Interventions

Case group:None
Control group:None

Sponsors

Fujian Provincial Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients with intracranial germ cell tumors; 2.With complete clinical data (imaging, pathological reports, follow-up records, etc.); 3.Patients with preserved paraffin-embedded tumor tissue samples;

Exclusion criteria

Exclusion criteria: 1.Patients with pure germinoma; 2.With concomitant other central nervous system tumors; 3.Patients whom the researchers deem unsuitable for the study;

Design outcomes

Primary

MeasureTime frame
Whether teratoma growth syndrome occurs and the occurrence time;Genomic methylation pattern;

Secondary

MeasureTime frame
Age;Treatment methods;Initial diagnosis pathological type;Gender;Tumor markers;Tumor location;Imaging features;

Countries

China

Contacts

Public ContactJing Junjie

Fujian Provincial Children's Hospital

jjj0709@sina.com+86 591 86112247

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026